Renal stone. Encounter for examination for normal comparison and control in clinical research program
Conditions
Interventions
Intervention 1: Intervention group: Patients with prevous history of observing the intact pills of Extended-release Urocitra in feces (without chronic diarrhea), will treated by potassium citrate ext
Sponsors
Sobhan darou Co
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: Urolithiasis patients with and without observing extended release Urocitra in feces
Exclusion criteria
Exclusion criteria: chronic kidney disease (stage 3&4) pregnancy or lactation
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 24-hour urine citrate. Timepoint: after 4 weeks treatment with Extended-release Urocitra. Method of measurement: 24- hour urine citrat measurment (enzymatic), mg/day.;Urine pH. Timepoint: after 4 weeks treatment with Extended-release Urocitra. Method of measurement: Measurement of fresh urine pH by pH meter.;Investigation of the possibility of recurrence of observing intact pills in the feces of patients with previous proclem. Timepoint: After four weeks. Method of measurement: Questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAbbas Basiri
Shahid Beheshti University of Medical Sciences
Outcome results
None listed